title: A diverse portfolio of novel drug discovery efforts for Alzheimer's disease: Meeting report from the 11th International Conference on Alzheimer's Drug Discovery, 27-28 September 2010, Jersey City, NJ, USA.
abstract: While Alzheimer's disease researchers continue to debate the underlying cause(s) of the disease, most agree that a diverse, multi-target approach to treatment will be necessary. To this end, the Alzheimer's Drug Discovery Foundation (ADDF) recently hosted the 11th International Conference on Alzheimer's Drug Discovery to highlight the array of exciting efforts from the ADDF's funded investigators.
authors.affiliation: Center for Neurobiology and Behavior, Columbia University, 630 West 168th Street, P&S 12-510, New York, NY 10032, USA. LL2429@columbia.edu.
authors.forename: Linda H
authors.initials: LH
authors.lastname: Lee
authors.forename: Diana W
authors.initials: DW
authors.lastname: Shineman
authors.forename: Howard M
authors.initials: HM
authors.lastname: Fillit